Breaking News

Aragen to Open New Formulation Manufacturing Facility in Hyderabad, India by January 2023

The 12,000 square foot new facility will strengthen the company’s ability to deliver clinical supplies to customers.

Author Image

By: Charlie Sternberg

Associate Editor

Aragen, a Contract Research Development and Manufacturing Organization (CRDMO), has announced that it will operationalize its formulation manufacturing facility in the Mallapur campus, Hyderabad, India by January 2023.   The 12,000 ft2 new facility will strengthen the company’s ability to deliver clinical supplies to customers through its integrated drug substance and drug product development and manufacturing.   The new plant will include a wide range of dosage form capabilities for oral so...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters